Coagulopathy and COVID?19

Caused by severe acute respiratory syndrome?coronavirus?2 (SARS?CoV?2), coronavirus disease2019 (COVID?19) is a potentially fatal disease as a global public health issue. Several mechanismsmay be involved in mortality. One of these is coagulopathy and disseminated intravascular coagulationcaused by SARS?CoV?2. When patients have coagulation disorders, treatment becomes morechallenging and mortality rate increases accordingly. The aim of this article is to review the potentialmechanisms of coagulopathy in COVID?19 in light of literature data.WOS:00057860380001

Disease history of patients with COPD

BACKGROUND AND AIM: This study aimed to obtain real-life data of patients diagnosed with chronic obstructive pulmonary disease (COPD) at least one year ago, including smoking history, inhaler device training, and the number of exacerbations. METHODS: This study was planned as a nationwide, prospective, observational, multicenter, and noninterventional study, and web-based electronic case forms were used to register the patients. RESULTS: A total of 460 patients from 11 centers were included, of whom 88.3% were males. Of the total patients, 137 (29.8%) were current smokers, and 292 (63.5%) were ex-smokers. One hundred twenty-four (29.6%) patients did not receive inhaler device training. Repeated inhaler device training in the follow-up visits was not performed in 255 (60.8%) patients. Of the total participants, 187 (41.0%) reported no exacerbations in the previous year. The mean number of exacerbations per person over the previous year was 1.19. The annual rates of influenza and pneumococcal vaccines were 34.8% and 4.2%, respectively. CONCLUSIONS: Patients should be trained more efficiently in the risks of COPD, use of inhaler devices, exacerbations, and improving quality of life

Are elderly and aged asthma different diseases? Results of a multicenter study

28th International Congress of the European-Respiratory-Society (ERS) -- SEP 15-19, 2018 -- Paris, FRANCEGemicioglu, Bilun/0000-0001-5953-4881; aydin, omur/0000-0002-3670-1728; Dursun, A. Berna/0000-0002-6337-6326; GOKSEL, Ozlem/0000-0003-1121-9967WOS: 000455567107243…European Respiratory So

Are elderly and aged asthma different diseases? Results of a multicenter study

28th International Congress of the European-Respiratory-Society (ERS) -- SEP 15-19, 2018 -- Paris, FRANCEaydin, omur/0000-0002-3670-1728; GOKSEL, Ozlem/0000-0003-1121-9967; Dursun, A. Berna/0000-0002-6337-6326; Gemicioglu, Bilun/0000-0001-5953-4881WOS: 000455567107243[No abstract available]European Respiratory So

The case of idiopathic pleuroparenchymal fibroelastosis diagnosed by transbronchial biopsy

Pleuroparenchymal fibroelastosis (PPFE) is claasified in idiopathic interstitial pneumonitis group is rarely seen. Etiology and pathophysiology of this entity are not completely understood. The prognosis is poor, and there is no effective treatment except for lung transplantation. Here, we presented a case of PPFE diagnosed by transbronchial biopsy through fiberoptic bronchoscopy and its histopathological and clinicoradiological features